Hikma Pharmaceuticals PLC is a multinational pharmaceutical company that develops, manufactures, and supplies generic and branded medicines. Founded in 1978 in Amman, Jordan, and headquartered in London, the company operates through three core businesses—Injectables, Generics, and Branded—serving hospitals, wholesalers, and pharmacies across the United States, Europe, and the Middle East and North Africa.
Hikma’s portfolio spans sterile injectables and oral solid dose products across therapeutic areas such as anti-infectives, cardiovascular, oncology, pain management, and central nervous system care. The company maintains an international manufacturing and R&D network in the US, Europe, and MENA, producing complex and hospital-critical products including lyophilized and cytotoxic injectables. Hikma is listed on the London Stock Exchange.
To provide comprehensive coverage, we aggregate data and news under the name Hikma Pharmaceuticals, encompassing the following company names, divisions, and related entities:
Hikma.
This list encompasses current and former names, alternate names, and key divisions associated with Hikma Pharmaceuticals, ensuring you can easily find all relevant information under a single, unified profile.